These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18832433)

  • 21. Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.
    Piper BJ; Meyer JS
    Neurotoxicol Teratol; 2006; 28(1):95-102. PubMed ID: 16271852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression.
    Rothman RB; Jayanthi S; Cadet JL; Wang X; Dersch CM; Baumann MH
    Ann N Y Acad Sci; 2004 Oct; 1025():151-61. PubMed ID: 15542713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain serotonin transporter in human methamphetamine users.
    Kish SJ; Fitzmaurice PS; Boileau I; Schmunk GA; Ang LC; Furukawa Y; Chang LJ; Wickham DJ; Sherwin A; Tong J
    Psychopharmacology (Berl); 2009 Mar; 202(4):649-61. PubMed ID: 18841348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
    J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
    McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.
    Schenk S; Hely L; Lake B; Daniela E; Gittings D; Mash DC
    Eur J Neurosci; 2007 Dec; 26(11):3229-36. PubMed ID: 18005064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.
    Meyer JS; Piper BJ; Vancollie VE
    Ann N Y Acad Sci; 2008 Oct; 1139():151-63. PubMed ID: 18991859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding.
    Piper BJ; Fraiman JB; Meyer JS
    Dev Psychobiol; 2005 Sep; 47(2):145-57. PubMed ID: 16136551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns.
    Adori C; Andó RD; Kovács GG; Bagdy G
    J Comp Neurol; 2006 Jul; 497(2):251-69. PubMed ID: 16705678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ecstasy: are animal data consistent between species and can they translate to humans?
    Easton N; Marsden CA
    J Psychopharmacol; 2006 Mar; 20(2):194-210. PubMed ID: 16510478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rat brain serotonin neurones that express neuronal nitric oxide synthase have increased sensitivity to the substituted amphetamine serotonin toxins 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
    De Silva DJ; French SJ; Cheung NY; Swinson AK; Bendotti C; Rattray M
    Neuroscience; 2005; 134(4):1363-75. PubMed ID: 16054768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
    Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
    J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J; Pubill D; Escubedo E
    Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats.
    Piper BJ; Farelli JD; Meyer JS
    Dev Neurosci; 2009; 31(1-2):90-4. PubMed ID: 19372690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
    Vegting Y; Reneman L; Booij J
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period.
    Piper BJ; Meyer JS
    Pharmacol Biochem Behav; 2004 Dec; 79(4):723-31. PubMed ID: 15582680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA; Martello AL; Katz JL; Martello MB
    J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.
    Szapacs ME; Mathews TA; Tessarollo L; Ernest Lyons W; Mamounas LA; Andrews AM
    J Neurosci Methods; 2004 Dec; 140(1-2):81-92. PubMed ID: 15589338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.